COMMUNIQUÉS West-GlobeNewswire

Medtronic to Provide Public Comment During CMS Committee Meeting on Volume Requirements for Transcatheter Aortic Valve Replacement (TAVR)
25/07/2018
Company to Emphasize the Importance of Evidenced-Based Quality Outcomes and Appropriate Patient Access DUBLIN and BALTIMORE - July 25, 2018 - Medtronic plc (NYSE:MDT), a global leader in heart valve therapies, will [...]
resTORbio Announces Positive Topline Results in Phase 2b Trial of RTB101
25/07/2018
-- Statistically significant and clinically meaningful 30.6% reduction in the percentage of patients with one or more laboratory-confirmed respiratory tract infections (RTIs), the primary endpoint of the trial, in the [...]
Midatech Pharma PLC: Trading Update
25/07/2018
25 July 2018 Midatech Pharma PLC (“Midatech”, “Company” or “Group”) Trading Update Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising [...]
AxoGen, Inc. to Present at Canaccord Genuity Growth Conference
25/07/2018
ALACHUA, Fla., July 25, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Peter J. Mariani, Chief [...]
miRagen Therapeutics to Report Second Quarter 2018 Financial Results and Host Conference Call on August 7, 2018
25/07/2018
BOULDER, Colo., July 25, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will host a [...]
ImmuCell Announces Sale of Certain Non-Core Assets
25/07/2018
PORTLAND, Maine, July 25, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq:ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Integra LifeSciences Reports Second Quarter 2018 Financial Results
25/07/2018
Revenue Increased 29.8% to $366.2 million; Organic Revenue Increased 3.4% Reported EPS of $0.14; Adjusted EPS of $0.60 Raises Low-End of Full-Year Total Revenue and EPS Guidance Successfully Exits First Wave of Codman [...]
Natus Medical Announces Second Quarter Financial Results
25/07/2018
Reports record second quarter revenue of $130.7 million Reports second quarter GAAP loss per share of $0.08 and non-GAAP earnings per share of $0.35 Updates annual revenue and earnings guidance for 2018 PLEASANTON, [...]
PotNetwork Holdings, Inc.’s Diamond CBD Continues Record Breaking Trend with Over $2 Million In Revenues Generated In June
25/07/2018
Year Over Year Sales Practically Double Again with Year-To-Date Sales Now Exceeding $12 Million for Only Six Months FT LAUDERDALE, Fla., July 25, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holdings, Inc. (OTC [...]
Shire plc : Rule 2.9 Announcement
25/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 25 July 2018 Shire [...]
ObsEva Expands Executive Team Hiring a Chief Commercial Officer
25/07/2018
Geneva, Switzerland and Boston, MA - July 25, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]
Reata Pharmaceuticals, Inc. Announces Pricing of Class A Common Stock Public Offering
25/07/2018
IRVING, Texas, July 24, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of 3,000,000 shares [...]
Abattis Completes Investment in XLABS Therapeutics to Launch New Cannabis Lab in Ontario
25/07/2018
VANCOUVER, British Columbia, July 24, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its news release dated June 28, [...]
Psychemedics Announces 2Q Record Revenues
24/07/2018
Declares 88th Consecutive Quarterly Dividend ACTON, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced second quarter financial results for the period ended June 30, 2018. The [...]
Assure Holdings Corp. Announces Update
24/07/2018
PARKER, Colo., July 24, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV:IOM) (OTCQB:ARHH) is providing an update relating to the appointment of its new auditor and an update relating [...]
N.M. Medical Cannabis Program Surging Toward $100 Million in 2018
24/07/2018
Two licensed producers generate half of New Mexico’s cannabis industry growth ALBUQUERQUE, N.M., July 24, 2018 (GLOBE NEWSWIRE) -- The 35 commercial producers in New Mexico surpassed $51 million in patient sales for the [...]
BioDelivery Sciences to Report Second-Quarter 2018 Financial Results on August 9, 2018
24/07/2018
RALEIGH, N.C., July 24, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) today announced that it will report its second quarter 2018 financial results after the close of the U.S. Financial [...]
BeiGene Initiates Phase 3 Pivotal Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-Line Treatment for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer in China
24/07/2018
BEIJING, China, and CAMBRIDGE, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted [...]
Radius Health Provides Update on Appeal of CHMP Opinion for Abaloparatide-SC
24/07/2018
WALTHAM, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine [...]

Pages